Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific AHSA2 DKFZp564C236, Hch1 ENSG00000173209 AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) 2 61177418-61191203 Predicted intracellular proteins Evidence at protein level HPA051137 Approved Approved Vesicles
Microtubules
Cytokinetic bridge Renal cancer:4.11e-6 (unfavourable), Urothelial cancer:1.85e-4 (favourable) Expressed in all Expressed in all spleen: 41.9 AIDA C1orf80, FLJ12806 ENSG00000186063 Axin interactor, dorsalization associated 1 222668013-222713210 Predicted intracellular proteins Evidence at protein level HPA027935 Approved Approved Microtubules
Cytokinetic bridge
Cytosol Cervical cancer:7.08e-5 (unfavourable), Renal cancer:4.37e-4 (unfavourable) Expressed in all Expressed in all testis: 79.9 APC2 APCL ENSG00000115266 Adenomatosis polyposis coli 2 19 1446302-1473244 Predicted intracellular proteins Evidence at protein level HPA078002 Approved Cytokinetic bridge
Midbody ring
Cytosol Tissue enriched Tissue enriched 21 cerebral cortex: 70.7 adrenal gland: 3.3 ARHGAP39 CrGAP, KIAA1688, Vilse ENSG00000147799 Rho GTPase activating protein 39 8 144529179-144605816 Predicted intracellular proteins Evidence at protein level HPA044491 Approved Nucleoplasm
Microtubules
Cytokinetic bridge
Cytosol Expressed in all Tissue enhanced testis: 16.5 cerebral cortex: 7.3 B4GALNT4 FLJ25045, NGalNAc-T1 ENSG00000182272 Beta-1,4-N-acetyl-galactosaminyl transferase 4 11 369796-382116 Enzymes, Predicted secreted proteins Evidence at protein level HPA053126 Uncertain Approved Nucleoplasm
Microtubules
Cytokinetic bridge
Mitotic spindle Mixed Tissue enhanced cerebral cortex: 30.9;ovary: 11.7 endometrium: 6.9 BIRC5 API4, EPR-1, survivin ENSG00000089685 Baculoviral IAP repeat containing 5 17 78214186-78225636 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA002830, CAB004270 Supported Validated Cytokinetic bridge Renal cancer:0.00e+0 (unfavourable), Liver cancer:5.28e-6 (unfavourable), Lung cancer:4.49e-4 (unfavourable) Expressed in all Tissue enhanced testis: 26.7 bone marrow: 22.7 C12orf66 FLJ32549 ENSG00000174206 Chromosome 12 open reading frame 66 12 64186316-64222296 Predicted intracellular proteins Evidence at protein level HPA046743, HPA052855 Uncertain Validated Microtubules
Cytokinetic bridge
Mitotic spindle Expressed in all Expressed in all parathyroid gland: 12.1 C17orf100 LOC388327 ENSG00000279257 Chromosome 17 open reading frame 100 17 6651914-6652270 Predicted intracellular proteins Evidence at protein level HPA046824 Uncertain Uncertain Nucleus
Cytokinetic bridge
Cytosol Not detected Mixed skin: 13.0 C21orf91 C21orf14, C21orf38, CSSG1, EURL, YG81 ENSG00000154642 Chromosome 21 open reading frame 91 21 17788967-17819386 Predicted intracellular proteins Evidence at protein level HPA018288, HPA049030 Approved Approved Microtubules
Cytokinetic bridge Expressed in all Mixed testis: 44.2 C4orf27 FLJ20534 ENSG00000056050 Chromosome 4 open reading frame 27 4 169729465-169757953 Predicted intracellular proteins Evidence at protein level HPA043467 Uncertain Approved Microtubules
Cytokinetic bridge
Cytosol Melanoma:5.63e-4 (unfavourable), Ovarian cancer:7.47e-4 (favourable) Expressed in all Expressed in all endometrium: 38.3 CAMKV MGC8407, VACAMKL ENSG00000164076 CaM kinase-like vesicle-associated 3 49857988-49870222 Enzymes, Predicted intracellular proteins Evidence at protein level HPA007656, CAB034931 Supported Approved Nucleoplasm
Cytokinetic bridge Group enriched Tissue enriched 55 cerebral cortex: 86.5 testis: 1.5 CCSAP C1orf96, CSAP, FLJ41471 ENSG00000154429 Centriole, cilia and spindle-associated protein 1 229321005-229343294 Predicted intracellular proteins Evidence at protein level HPA028402, HPA043443 Supported Uncertain Nucleoplasm
Cytokinetic bridge Renal cancer:4.50e-13 (unfavourable), Liver cancer:1.41e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 54.2 placenta: 18.6 CDC42 CDC42Hs, G25K ENSG00000070831 Cell division cycle 42 1 22052627-22092946 Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level CAB004360 Approved Validated Microtubules
Cytokinetic bridge Liver cancer:5.28e-5 (unfavourable) Expressed in all Expressed in all bone marrow: 253.0 CDC7 CDC7L1, HsCdc7, Hsk1, huCdc7 ENSG00000097046 Cell division cycle 7 1 91500893-91525764 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB002669, HPA035831 Approved Supported Nucleoplasm
Cytokinetic bridge
Mitotic spindle Renal cancer:1.89e-15 (unfavourable), Liver cancer:3.15e-6 (unfavourable) Expressed in all Tissue enhanced testis: 31.9 spleen: 17.4 CDCA8 BOR, DasraB, FLJ12042, MESRGP ENSG00000134690 Cell division cycle associated 8 1 37692418-37709719 Predicted intracellular proteins Evidence at protein level HPA028120, HPA028258, HPA028783, CAB040294 Supported Validated Nucleoli
Cytokinetic bridge Renal cancer:0.00e+0 (unfavourable), Liver cancer:4.93e-10 (unfavourable), Melanoma:6.04e-4 (unfavourable), Pancreatic cancer:8.32e-4 (unfavourable) Expressed in all Tissue enhanced testis: 36.5 lymph node: 23.3 CELF2 BRUNOL3, CUGBP2, Etr-3, NAPOR-2 ENSG00000048740 CUGBP, Elav-like family member 2 10 11005321-11336675 Predicted intracellular proteins Evidence at protein level CAB016395, HPA035813, HPA065098 Supported Uncertain Nucleoplasm
Microtubules
Cytokinetic bridge Head and neck cancer:7.61e-4 (favourable) Expressed in all Mixed cerebral cortex: 76.6 CEP131 AZ1, AZI1, KIAA1118 ENSG00000141577 Centrosomal protein 131kDa 17 81189593-81222999 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA024019 Approved Supported Microtubules
Cytokinetic bridge
Microtubule organizing center Liver cancer:9.68e-5 (unfavourable) Expressed in all Mixed testis: 17.3 CISH CIS, CIS-1, G18, SOCS ENSG00000114737 Cytokine inducible SH2-containing protein 3 50606490-50611831 Predicted intracellular proteins Evidence at protein level CAB034039, HPA040812 Approved Approved Microtubules
Cytokinetic bridge Renal cancer:3.53e-12 (favourable), Endometrial cancer:1.13e-5 (favourable), Liver cancer:6.98e-4 (favourable), Pancreatic cancer:9.65e-4 (favourable) Expressed in all Mixed thyroid gland: 42.9 CNFN PLAC8L2 ENSG00000105427 Cornifelin 19 42387019-42390287 Predicted intracellular proteins Evidence at protein level HPA049073, HPA053997 Supported Approved Microtubules
Cytokinetic bridge Thyroid cancer:4.02e-5 (favourable) Expressed in all Group enriched 33 esophagus: 1163.5;skin: 272.0;tonsil: 270.8 breast: 17.4 COPS2 ALIEN, CSN2, TRIP15 ENSG00000166200 COP9 signalosome subunit 2 15 49106068-49155661 Predicted intracellular proteins Evidence at protein level HPA016867, HPA018271, HPA061071 Approved Validated Vesicles
Cytokinetic bridge Expressed in all Expressed in all thyroid gland: 103.1 DESI1 D15Wsu75e, FAM152B, PPPDE2 ENSG00000100418 Desumoylating isopeptidase 1 22 41598028-41621096 Predicted intracellular proteins Evidence at protein level HPA053415 Approved Approved Cytokinetic bridge
Cytosol Endometrial cancer:7.70e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 29.6 DNHD1 C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184 ENSG00000179532 Dynein heavy chain domain 1 11 6497260-6593758 Predicted intracellular proteins Evidence at protein level HPA039698, HPA040267, HPA057639 Uncertain Approved Nucleoplasm
Cytokinetic bridge Mixed Tissue enriched 6 testis: 19.5 bone marrow: 3.5 DOK4 FLJ10488 ENSG00000125170 Docking protein 4 16 57471922-57487327 Predicted intracellular proteins Evidence at protein level HPA055849 Supported Approved Vesicles
Microtubules
Cytokinetic bridge Expressed in all Expressed in all small intestine: 55.8 DUSP11 PIR1 ENSG00000144048 Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) 2 73762184-73780157 Predicted intracellular proteins Evidence at protein level HPA021052 Supported Nucleus
Nucleoli fibrillar center
Cytokinetic bridge Liver cancer:2.10e-7 (unfavourable) Expressed in all Expressed in all fallopian tube: 61.9 DZIP1L DZIP2, FLJ32844 ENSG00000158163 DAZ interacting zinc finger protein 1-like 3 138061990-138115818 Predicted intracellular proteins Evidence at protein level HPA030404 Approved Approved Nucleoplasm
Microtubules
Cytokinetic bridge Mixed Mixed fallopian tube: 16.5 EMC1 KIAA0090 ENSG00000127463 ER membrane protein complex subunit 1 1 19215664-19251552 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA048904 Approved Approved Microtubules
Cytokinetic bridge Liver cancer:8.56e-6 (unfavourable), Urothelial cancer:1.43e-4 (unfavourable) Expressed in all Expressed in all placenta: 34.3 ESRRA ERR1, ERRa, ERRalpha, ESRL1, NR3B1 ENSG00000173153 Estrogen-related receptor alpha 11 64305572-64316743 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053785 Approved Nucleus
Nucleoli fibrillar center
Microtubules
Cytokinetic bridge Renal cancer:1.34e-7 (favourable) Expressed in all Expressed in all duodenum: 89.0 FAM50B D6S2654E, X5L ENSG00000145945 Family with sequence similarity 50, member B 6 3849386-3851317 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA064111, HPA067817 Approved Validated Nucleoplasm
Cytokinetic bridge Renal cancer:4.01e-6 (favourable) Expressed in all Expressed in all cerebral cortex: 16.1 FAN1 KIAA1018, MTMR15 ENSG00000198690 FANCD2/FANCI-associated nuclease 1 15 30903852-30943108 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA048198 Supported Nucleoplasm
Cytokinetic bridge
Cytosol Renal cancer:1.42e-6 (favourable) Expressed in all Expressed in all prostate: 9.8 FBXO38 Fbx38, FLJ13962, MOKA, SP329 ENSG00000145868 F-box protein 38 5 148383935-148442836 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA034821, HPA041444 Approved Supported Nucleoplasm
Plasma membrane
Cytokinetic bridge
Cytosol Expressed in all Expressed in all parathyroid gland: 30.2 FCGBP FC(GAMMA)BP ENSG00000275395 Fc fragment of IgG binding protein 19 39863323-39934626 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA003517, HPA003564 Supported Approved Golgi apparatus
Plasma membrane
Cytokinetic bridge Ovarian cancer:9.70e-6 (unfavourable), Head and neck cancer:1.28e-5 (favourable), Liver cancer:4.74e-5 (unfavourable), Thyroid cancer:4.27e-4 (unfavourable) Expressed in all Tissue enhanced colon: 194.4 thyroid gland: 109.6 FOXL2 BPES, BPES1 ENSG00000183770 Forkhead box L2 3 138944224-138947140 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA069613 Supported Supported Nucleus
Cytokinetic bridge Mixed Tissue enhanced endometrium: 12.1;ovary: 29.6;parathyroid gland: 24.2 fallopian tube: 7.6 FOXN3 C14orf116, CHES1 ENSG00000053254 Forkhead box N3 14 89124871-89619149 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059209 Approved Approved Nucleus
Plasma membrane
Cytokinetic bridge Renal cancer:9.58e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 109.4 FRYL AF4p12, DKFZp686E205, KIAA0826 ENSG00000075539 FRY-like 4 48497361-48780322 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA031106, HPA031107 Supported Approved Microtubules
Cytokinetic bridge
Cytosol Expressed in all Expressed in all parathyroid gland: 50.3 FUT9 Fuc-TIX ENSG00000172461 Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) 6 96015984-96215612 Predicted membrane proteins Evidence at protein level HPA070923 Approved Nucleoplasm
Microtubules
Cytokinetic bridge
Cytosol Tissue enhanced Group enriched 12 cerebral cortex: 28.2;stomach: 22.2 duodenum: 2.1 GDPD3 MGC4171 ENSG00000102886 Glycerophosphodiester phosphodiesterase domain containing 3 16 30104810-30113856 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA041148, HPA041470 Uncertain Approved Nucleoplasm
Cytokinetic bridge
Cytosol Renal cancer:5.89e-9 (unfavourable) Expressed in all Mixed esophagus: 23.2 GLI4 HKR4, ZNF928 ENSG00000250571 GLI family zinc finger 4 8 143267433-143276931 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023131 Uncertain Approved Nucleus
Cytokinetic bridge Expressed in all Expressed in all spleen: 9.0 GXYLT2 GLT8D4 ENSG00000172986 Glucoside xylosyltransferase 2 3 72888073-72998138 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA068429 Uncertain Approved Nucleoplasm
Cytokinetic bridge
Midbody ring Renal cancer:1.46e-7 (unfavourable), Urothelial cancer:2.42e-5 (unfavourable) Mixed Mixed ovary: 20.5 IQCB1 KIAA0036, NPHP5, SLSN5 ENSG00000173226 IQ motif containing B1 3 121769763-121835079 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA042028 Supported Microtubules
Cytokinetic bridge
Mitotic spindle Liver cancer:3.08e-5 (unfavourable), Cervical cancer:1.77e-4 (favourable), Lung cancer:3.67e-4 (favourable) Expressed in all Expressed in all testis: 52.2 ITFG2 MDS028 ENSG00000111203 Integrin alpha FG-GAP repeat containing 2 12 2812622-2859791 Predicted intracellular proteins Evidence at protein level HPA038664, HPA038665 Uncertain Approved Nucleoplasm
Endoplasmic reticulum
Cytokinetic bridge Expressed in all Expressed in all thyroid gland: 45.8 KIAA1143 ENSG00000163807 KIAA1143 3 44737661-44761662 Predicted intracellular proteins Evidence at protein level HPA045018, HPA061799 Approved Approved Nucleus
Cytokinetic bridge Renal cancer:3.26e-6 (favourable), Colorectal cancer:3.65e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 15.1 KIAA1211L C2orf55, MGC42367 ENSG00000196872 KIAA1211-like 2 98793846-98936259 Predicted intracellular proteins Evidence at protein level HPA051082, HPA061678 Uncertain Approved Microtubules
Cytokinetic bridge
Centrosome Renal cancer:1.13e-5 (favourable), Thyroid cancer:1.33e-5 (favourable) Expressed in all Tissue enhanced cerebral cortex: 36.9;epididymis: 38.1 fallopian tube: 35.8 KIF18A DKFZP434G2226, PPP1R99 ENSG00000121621 Kinesin family member 18A 11 28020620-28108308 Predicted intracellular proteins Evidence at protein level HPA039312, HPA039484 Approved Supported Microtubules
Cytokinetic bridge Mixed Tissue enhanced testis: 23.3 lymph node: 5.3 KIF4A FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100 ENSG00000090889 Kinesin family member 4A X 70290090-70420832 Predicted intracellular proteins Evidence at protein level HPA034745, HPA034746, HPA061583 Approved Validated Nucleoplasm
Cytokinetic bridge Liver cancer:7.37e-6 (unfavourable), Pancreatic cancer:9.44e-6 (unfavourable) Mixed Mixed bone marrow: 7.0 KLK6 Bssp, Klk7, neurosin, PRSS18, PRSS9 ENSG00000167755 Kallikrein-related peptidase 6 19 50958631-50969673 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA051837 Supported Nucleoplasm
Nuclear membrane
Cytokinetic bridge Endometrial cancer:1.38e-5 (unfavourable), Urothelial cancer:1.27e-4 (unfavourable), Pancreatic cancer:7.82e-4 (unfavourable), Lung cancer:8.85e-4 (unfavourable) Tissue enhanced Group enriched 5 cerebral cortex: 79.0;esophagus: 63.2;fallopian tube: 44.3;tonsil: 32.5 kidney: 10.1 LACC1 C13orf31, FLJ38725 ENSG00000179630 Laccase (multicopper oxidoreductase) domain containing 1 13 43879284-43893932 Disease related genes, Predicted intracellular proteins Evidence at protein level CAB034228, HPA040150, HPA044211 Uncertain Approved Nucleoplasm
Cytokinetic bridge
Cytosol Expressed in all Mixed testis: 17.1 LARP6 acheron, FLJ11196 ENSG00000166173 La ribonucleoprotein domain family, member 6 15 70829130-70854159 Predicted intracellular proteins Evidence at protein level HPA020338, HPA049029 Approved Approved Microtubules
Cytokinetic bridge Renal cancer:9.90e-5 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 84.9 thyroid gland: 40.7 LRRC34 MGC27085 ENSG00000171757 Leucine rich repeat containing 34 3 169793428-169812986 Predicted intracellular proteins Evidence at protein level HPA035747, HPA058105 Approved Approved Cell Junctions
Microtubules
Cytokinetic bridge Mixed Group enriched 8 fallopian tube: 12.2;testis: 26.8 cerebral cortex,thyroid gland: 2.3 MAGEE1 DAMAGE, KIAA1587 ENSG00000198934 Melanoma antigen family E1 X 76427724-76431353 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA003047 Approved Approved Cytokinetic bridge
Cytosol Renal cancer:6.86e-6 (favourable), Pancreatic cancer:3.95e-4 (favourable) Mixed Tissue enhanced cerebral cortex: 29.9 parathyroid gland: 14.0 MEGF6 EGFL3 ENSG00000162591 Multiple EGF-like-domains 6 1 3489920-3611495 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA052129 Uncertain Approved Microtubules
Cytokinetic bridge Colorectal cancer:3.08e-4 (unfavourable), Head and neck cancer:6.57e-4 (favourable) Expressed in all Tissue enhanced skin: 48.3 gallbladder: 17.1 MRRF RRF ENSG00000148187 Mitochondrial ribosome recycling factor 9 122264603-122331343 Predicted intracellular proteins Evidence at protein level HPA047177, HPA049987 Supported Approved Microtubules
Cytokinetic bridge Renal cancer:2.14e-8 (favourable) Expressed in all Expressed in all parathyroid gland: 33.9 MTCL1 CCDC165, KIAA0802, SOGA2 ENSG00000168502 Microtubule crosslinking factor 1 18 8705661-8832778 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA046245 Uncertain Approved Nucleoplasm
Cytokinetic bridge Renal cancer:5.19e-4 (unfavourable), Cervical cancer:6.45e-4 (unfavourable) Mixed Mixed gallbladder: 12.8 MTUS2 CAZIP, ICIS, KIAA0774, TIP150 ENSG00000132938 Microtubule associated tumor suppressor candidate 2 13 28820348-29505947 Predicted intracellular proteins Evidence at protein level HPA031473, HPA031474, HPA031475 Approved Supported Microtubules
Cytokinetic bridge Mixed Tissue enhanced heart muscle: 32.6;ovary: 9.5 cerebral cortex: 4.3 NCAPH2 384D8-2, CAP-H2, hCAP-H2 ENSG00000025770 Non-SMC condensin II complex, subunit H2 22 50508216-50523472 Predicted intracellular proteins Evidence at protein level HPA067932, HPA069056 Supported Validated Nucleoplasm
Cytokinetic bridge Cervical cancer:2.24e-8 (favourable), Liver cancer:8.25e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 49.6 NINL KIAA0980, NLP ENSG00000101004 Ninein-like 20 25452705-25585517 Predicted intracellular proteins Evidence at protein level HPA000686 Uncertain Approved Cytokinetic bridge
Cytosol Renal cancer:1.03e-5 (favourable), Pancreatic cancer:1.47e-4 (favourable) Expressed in all Mixed parathyroid gland: 17.6 NPTN GP55, GP65, np55, np65, SDFR1, SDR1 ENSG00000156642 Neuroplastin 15 73560014-73634134 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA051497, HPA072453 Approved Approved Cytokinetic bridge
Mitochondria Expressed in all Expressed in all smooth muscle: 428.0 PCIF1 bA465L10.1, C20orf67, PPP1R121 ENSG00000100982 PDX1 C-terminal inhibiting factor 1 20 45934628-45948023 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA049517 Supported Supported Nucleoplasm
Microtubules
Cytokinetic bridge Renal cancer:1.50e-6 (favourable), Endometrial cancer:8.86e-4 (unfavourable) Expressed in all Expressed in all fallopian tube: 48.6 PDCD2 RP8, ZMYND7 ENSG00000071994 Programmed cell death 2 6 170575295-170584692 Predicted intracellular proteins Evidence at protein level HPA026713, HPA075534 Uncertain Approved Nucleoplasm
Cytokinetic bridge Liver cancer:1.42e-6 (unfavourable) Expressed in all Expressed in all thyroid gland: 59.8 PIK3CD p110D ENSG00000171608 Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 1 9651732-9729114 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level CAB015420, HPA044953 Approved Approved Vesicles
Cytokinetic bridge Expressed in all Tissue enhanced lymph node: 57.2 spleen: 52.1 PLEKHA4 PEPP1 ENSG00000105559 Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 19 48837097-48868632 Predicted intracellular proteins Evidence at protein level HPA042978, HPA048473 Uncertain Approved Plasma membrane
Cytokinetic bridge
Centrosome
Cytosol Breast cancer:1.97e-4 (favourable), Liver cancer:8.68e-4 (unfavourable) Expressed in all Mixed ovary: 22.5 PLEKHG3 ARHGEF43, KIAA0599 ENSG00000126822 Pleckstrin homology domain containing, family G (with RhoGef domain) member 3 14 64704102-64750247 Predicted intracellular proteins Evidence at protein level HPA063455, HPA065323 Supported Nucleoplasm
Plasma membrane
Cytokinetic bridge
Centrosome
Cytosol Renal cancer:7.39e-8 (favourable) Expressed in all Expressed in all seminal vesicle: 52.5 PPEF1 PPEF, PPP7CA ENSG00000086717 Protein phosphatase, EF-hand calcium binding domain 1 X 18675909-18827921 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA034577 Uncertain Uncertain Plasma membrane
Cytokinetic bridge Mixed Tissue enriched 7 testis: 26.2 cerebral cortex: 3.6 PRKCI DXS1179E, PKCI ENSG00000163558 Protein kinase C, iota 3 170222365-170305981 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level HPA026574, HPA038635 Approved Validated Microtubules
Cytokinetic bridge
Cytosol Endometrial cancer:3.93e-6 (unfavourable), Pancreatic cancer:1.22e-4 (unfavourable), Liver cancer:3.02e-4 (unfavourable), Renal cancer:3.10e-4 (favourable) Expressed in all Expressed in all thyroid gland: 39.6 PRR5L FLJ14213, PROTOR-2 ENSG00000135362 Proline rich 5 like 11 36296288-36465204 Predicted intracellular proteins Evidence at protein level HPA070174 Approved Cytokinetic bridge
Cytosol Renal cancer:7.71e-8 (unfavourable), Endometrial cancer:7.30e-5 (favourable), Stomach cancer:4.86e-4 (unfavourable) Expressed in all Tissue enhanced spleen: 51.9 colon: 35.6 PSMB8 beta5i, D6S216E, LMP7, PSMB5i, RING10 ENSG00000204264 Proteasome subunit beta 8 6 32840717-32844703 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA046995, HPA050327 Supported Approved Vesicles
Cytokinetic bridge Breast cancer:5.08e-4 (favourable), Endometrial cancer:7.16e-4 (favourable) Expressed in all Mixed lymph node: 23.3 RAB11FIP3 eferin, KIAA0665, Rab11-FIP3 ENSG00000090565 RAB11 family interacting protein 3 (class II) 16 425619-523011 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA028088, HPA028631, HPA030086 Approved Supported Vesicles
Cytokinetic bridge
Microtubule organizing center Pancreatic cancer:3.16e-5 (favourable), Liver cancer:9.87e-5 (unfavourable), Endometrial cancer:1.22e-4 (favourable), Renal cancer:7.99e-4 (favourable) Expressed in all Expressed in all kidney: 56.8 RAPGEFL1 Link-GEFII ENSG00000108352 Rap guanine nucleotide exchange factor (GEF)-like 1 17 40177010-40195656 Predicted intracellular proteins Evidence at protein level HPA022895 Approved Nucleus
Microtubules
Cytokinetic bridge Renal cancer:0.00e+0 (unfavourable), Cervical cancer:3.28e-4 (favourable), Breast cancer:8.43e-4 (favourable) Expressed in all Tissue enhanced skin: 277.6 esophagus: 93.6 RBM20 ENSG00000203867 RNA binding motif protein 20 10 110644397-110839469 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA035806, HPA037703 Uncertain Approved Nucleus
Nucleoli
Golgi apparatus
Cytokinetic bridge Mixed Tissue enhanced heart muscle: 26.5 skeletal muscle: 5.4 ROR1 NTRKR1 ENSG00000185483 Receptor tyrosine kinase-like orphan receptor 1 1 63774022-64181498 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA057016 Uncertain Microtubules
Cytokinetic bridge Mixed Tissue enhanced parathyroid gland: 51.2 endometrium: 12.1 SCN3B HSA243396 ENSG00000166257 Sodium channel, voltage gated, type III beta subunit 11 123629187-123655244 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA042518 Approved Nuclear membrane
Cytokinetic bridge Tissue enhanced Tissue enriched 11 cerebral cortex: 132.5 adrenal gland: 11.6 SETX ALS4, AOA2, KIAA0625, SCAR1 ENSG00000107290 Senataxin 9 132261356-132354985 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA024105, HPA057269 Approved Supported Nucleus
Cytokinetic bridge Expressed in all Expressed in all testis: 58.1 SH2D3A NSP1 ENSG00000125731 SH2 domain containing 3A 19 6752160-6767588 Predicted intracellular proteins Evidence at protein level HPA035722, HPA064382 Uncertain Approved Nucleoplasm
Microtubules
Cytokinetic bridge Renal cancer:1.42e-4 (favourable), Prostate cancer:6.21e-4 (unfavourable) Mixed Mixed duodenum: 14.2 SH3GL2 CNSA2, EEN-B1, SH3D2A, SH3P4 ENSG00000107295 SH3-domain GRB2-like 2 9 17579082-17797129 Predicted intracellular proteins Evidence at protein level CAB010056, HPA026685, HPA063573 Supported Supported Approved Microtubules
Cytokinetic bridge Renal cancer:6.68e-12 (favourable) Tissue enhanced Tissue enriched 10 cerebral cortex: 170.6 kidney: 17.3 SLC16A4 MCT4, MCT5 ENSG00000168679 Solute carrier family 16, member 4 1 110362848-110391082 Predicted membrane proteins Evidence at transcript level HPA046986, HPA060163 Approved Approved Microtubules
Cytokinetic bridge
Cytosol Renal cancer:1.69e-4 (favourable) Expressed in all Tissue enhanced kidney: 124.3 placenta: 39.9 SLC29A4 ENT4, FLJ34923 ENSG00000164638 Solute carrier family 29 (equilibrative nucleoside transporter), member 4 7 5274369-5306870 Predicted membrane proteins, Transporters Evidence at protein level HPA052829 Supported Microtubules
Cytokinetic bridge Pancreatic cancer:4.52e-4 (favourable) Expressed in all Tissue enhanced adipose tissue: 44.2 cerebral cortex: 12.0 SLFN13 FLJ31952 ENSG00000154760 Schlafen family member 13 17 35435096-35448837 Predicted intracellular proteins Evidence at protein level HPA022532, HPA023064 Uncertain Approved Cytokinetic bridge Cervical cancer:3.82e-4 (favourable) Mixed Mixed parathyroid gland: 40.4 SNPH bA314N13.5 ENSG00000101298 Syntaphilin 20 1266316-1309328 Predicted membrane proteins Evidence at protein level HPA049393 Approved Uncertain Cytokinetic bridge
Mitochondria Pancreatic cancer:6.97e-5 (favourable) Mixed Tissue enhanced cerebral cortex: 33.7 seminal vesicle: 15.4 SNRNP25 C16orf33 ENSG00000161981 Small nuclear ribonucleoprotein 25kDa (U11/U12) 16 53010-57669 Predicted intracellular proteins Evidence at protein level HPA041183, HPA044248 Uncertain Supported Nucleoplasm
Cytokinetic bridge
Cytosol Renal cancer:1.16e-5 (favourable), Cervical cancer:1.95e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 55.6 THAP11 CTG-B43a, CTG-B45d, HRIHFB2206 ENSG00000168286 THAP domain containing 11 16 67842082-67844195 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041434, HPA042189 Supported Validated Nucleoplasm
Cytokinetic bridge Expressed in all Expressed in all fallopian tube: 25.1 TIRAP Mal, wyatt ENSG00000150455 Toll-interleukin 1 receptor (TIR) domain containing adaptor protein 11 126283065-126298845 Predicted intracellular proteins Evidence at protein level HPA054431 Uncertain Approved Nucleoplasm
Cytokinetic bridge
Cytosol Endometrial cancer:1.24e-4 (favourable) Expressed in all Mixed parathyroid gland: 13.1 TMEFF2 CT120.2, HPP1, TENB2, TPEF, TR ENSG00000144339 Transmembrane protein with EGF-like and two follistatin-like domains 2 2 191949043-192195709 Predicted membrane proteins Evidence at protein level HPA015587 Uncertain Approved Microtubules
Cytokinetic bridge Tissue enriched Tissue enhanced cerebral cortex: 41.1;prostate: 54.9;seminal vesicle: 19.4 epididymis: 10.5 TMEM8A M83, TMEM6, TMEM8 ENSG00000129925 Transmembrane protein 8A 16 370773-387113 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA051281, HPA064673 Approved Supported Nucleoplasm
Cytokinetic bridge Renal cancer:1.29e-5 (favourable) Expressed in all Expressed in all testis: 57.6 TRIM45 FLJ13181, RNF99 ENSG00000134253 Tripartite motif containing 45 1 117111060-117122587 Predicted intracellular proteins Evidence at protein level HPA030266, HPA054308 Uncertain Supported Cytokinetic bridge
Cytosol Breast cancer:1.58e-4 (favourable), Thyroid cancer:2.92e-4 (unfavourable) Expressed in all Mixed fallopian tube: 14.3 VLDLR CARMQ1, CHRMQ1, VLDLRCH ENSG00000147852 Very low density lipoprotein receptor 9 2621834-2660053 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level CAB032462, HPA051312 Uncertain Approved Vesicles
Cytokinetic bridge
Microtubule organizing center Endometrial cancer:5.95e-4 (favourable) Expressed in all Tissue enhanced ovary: 109.9;parathyroid gland: 123.5 heart muscle: 44.5 XPA XP1, XPAC ENSG00000136936 Xeroderma pigmentosum, complementation group A 9 97674909-97697357 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level CAB000155, HPA056856 Supported Approved Nucleus
Cytokinetic bridge Renal cancer:4.28e-5 (favourable) Expressed in all Expressed in all thyroid gland: 38.9 ZBTB18 C2H2-171, RP58, TAZ-1, ZNF238 ENSG00000179456 Zinc finger and BTB domain containing 18 1 244048939-244057476 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044652 Supported Nucleoplasm
Microtubules
Cytokinetic bridge Urothelial cancer:6.78e-6 (favourable), Endometrial cancer:1.34e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 76.5 ZBTB24 BIF1, KIAA0441, PATZ2, ZNF450 ENSG00000112365 Zinc finger and BTB domain containing 24 6 109462594-109483237 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017872, HPA049003 Uncertain Approved Nucleus
Cytokinetic bridge
Centrosome Liver cancer:3.15e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 13.7 ZNF302 ZNF135L, ZNF140L, ZNF327 ENSG00000089335 Zinc finger protein 302 19 34677639-34686397 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059503 Approved Vesicles
Cytokinetic bridge Endometrial cancer:2.03e-5 (unfavourable), Urothelial cancer:9.85e-5 (favourable), Renal cancer:5.41e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 41.4